Doctor Pascal Burger
University Medical Center Utrecht, Utrecht (Netherlands (The))
Effects of icosapent ethyl on residual cardiovascular risk according to predicted baseline risk: results from REDUCE-IT
Event: ESC Congress 2023
Topic: Drug therapy
Session: What's new in lipid lowering?
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: a meta-analysis of 59 trials
Event: ESC Congress 2023
Topic: Drug therapy
Session: What's new in lipid lowering?
Inflammation and risk of recurrent cardiovascular events according to prior vascular disease location
Event: ESC Congress 2022
Topic: Secondary Prevention
Session: Secondary prevention 1
Individual lifetime benefit from low-dose colchicine in chronic coronary artery disease patients
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Inflammation and coronary artery disease
ESC 365 is supported by
